RA CAPITAL MANAGEMENT L.P. 13D and 13G filings for Artiva Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-03 4:18 pm Unchanged | 2024-08-29 | 13D | Artiva Biotherapeutics, Inc. ARTV | RA CAPITAL MANAGEMENT L.P. | 9,853,302 40.600% | 0 (Unchanged) | Filing |
| 2024-07-29 4:29 pm Purchase | 2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV | RA CAPITAL MANAGEMENT L.P. | 9,853,302 42.300% | 9,853,302 (New Position) | Filing |